Table 4.

Outputs for $S_j,R_j,Q_j$ and rank (EV case)

Anticancer drugs	$S_j$	$R_j$	$Q_j$	EV QSPR VIKOR rank
Alpelisib	0.565214	0.243236	0.588969	14
Azacitidine	0.713466	0.353477	0.874597	18
Cytarabine	0.7192	0.357522	0.885335	19
Daunorubicin	0.447335	0.169406	0.381419	7
Dexamethasone	0.538918	0.233123	0.551663	10
Docetaxel	0.222318	0.046624	0.010915	2
Doxorubicin	0.441535	0.16536	0.370623	5
Glasdegib	0.62183	0.289254	0.703591	16
Gilteritinib	0.505865	0.206827	0.485551	9
Ivosidenib	0.44394	0.166372	0.374157	6
Midostaurin	0.345751	0.099621	0.193843	4
Olaparib	0.558119	0.245259	0.585626	12
Paclitaxel	0.209837	0.0505	0.005484	1
Palbociclib	0.55258	0.241214	0.575058	11
Pamidronic acid	0.735507	0.366625	0.912475	20
Prednisone	0.557713	0.247788	0.588849	13
Ribociclib	0.568689	0.251327	0.603456	15
Tioguanine	0.781592	0.4	1	21
Toremifene	0.643363	0.301896	0.740309	17
Tucatinib	0.504656	0.206827	0.484494	8
Venetoclax	0.25069	0.050009	0.040515	3
$S_{+},R_{+}$	0.209837	0.046624
$S_{-},R_{-}$	0.781592	0.4